CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-03 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units | −27,558 | 55,101 | ||
| 2023-03-03 | List Alan Chief Medical Officer | Option exercise | +29,453 | 47,713 | ||
| 2023-03-03 | List Alan Chief Medical Officer | Option exercise · Restricted Stock Units | +29,453 | 58,890 | ||
| 2023-03-03 | SMITH J. JEFFERSON Chief Research Officer | Option exercise | +15,576 | 1,930,207 | ||
| 2023-03-03 | SMITH J. JEFFERSON Chief Research Officer | Option exercise · Restricted Stock Units | −15,576 | 31,144 | ||
| 2023-03-03 | Kelly John Alexander Chief Financial Officer | Option exercise | +51,071 | 225,614 | ||
| 2023-03-03 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −51,071 | 102,114 | ||
| 2023-03-03 | Barton Shane VP & Corporate Controller | Option exercise | +12,722 | 21,422 | ||
| 2023-03-03 | Barton Shane VP & Corporate Controller | Option exercise · Restricted Stock Units | −12,722 | 25,439 | ||
| 2023-02-28 | Scimeca Dario General Counsel and Secretary | Grant or award | +2,163 | $0.95 | $2K | 34,677 |
| 2023-02-28 | SMITH J. JEFFERSON Chief Research Officer | Grant or award | +12,157 | $0.95 | $12K | 1,914,631 |
| 2023-02-28 | Kelly John Alexander Chief Financial Officer | Grant or award | +11,605 | $0.95 | $11K | 174,543 |
| 2023-01-20 | SMITH J. JEFFERSON Chief Research Officer | Grant or award · Restricted Stock Units | +225,000 | 225,000 | ||
| 2023-01-20 | Kelly John Alexander Chief Financial Officer | Grant or award · Restricted Stock Units | +350,000 | 350,000 | ||
| 2023-01-20 | Barton Shane VP & Corporate Controller | Grant or award · Restricted Stock Units | +70,000 | 70,000 | ||
| 2023-01-20 | Amoroso Michael President and CEO | Grant or award · Restricted Stock Units | +800,000 | 800,000 | ||
| 2023-01-20 | List Alan Chief Medical Officer | Grant or award · Restricted Stock Units | +180,000 | 180,000 | ||
| 2023-01-20 | Scimeca Dario General Counsel and Secretary | Grant or award · Restricted Stock Units | +178,000 | 178,000 | ||
| 2022-11-02 | Scimeca Dario General Counsel and Secretary | Grant or award · Restricted Stock Units | +165,200 | 165,200 | ||
| 2022-11-02 | Kelly John Alexander Chief Financial Officer | Grant or award · Restricted Stock Units | +324,500 | 324,500 |
Page 14 of 23 · 456 trades